Unicycive Therapeutics, Inc. (UNCY)
5.29
-0.02
(-0.38%)
USD |
NASDAQ |
Sep 11, 16:00
5.29
0.00 (0.00%)
After-Hours: 20:00
Unicycive Therapeutics Enterprise Value : 86.67M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 86.67M |
| September 10, 2026 | 87.22M |
| September 09, 2026 | 81.93M |
| September 08, 2026 | 79.43M |
| September 04, 2026 | 83.05M |
| September 03, 2026 | 86.95M |
| September 02, 2026 | 83.88M |
| September 01, 2026 | 79.98M |
| August 31, 2026 | 84.16M |
| August 28, 2026 | 85.97M |
| August 27, 2026 | 92.52M |
| August 26, 2026 | 90.57M |
| August 25, 2026 | 91.68M |
| August 24, 2026 | 88.06M |
| August 21, 2026 | 96.14M |
| August 20, 2026 | 91.12M |
| August 19, 2026 | 94.75M |
| August 18, 2026 | 96.14M |
| August 17, 2026 | 94.47M |
| August 14, 2026 | 92.80M |
| August 13, 2026 | 89.73M |
| August 12, 2026 | 89.45M |
| August 11, 2026 | 78.59M |
| August 10, 2026 | 79.15M |
| August 07, 2026 | 80.54M |
| Date | Value |
|---|---|
| August 06, 2026 | 79.98M |
| August 05, 2026 | 85.00M |
| August 04, 2026 | 83.32M |
| August 03, 2026 | 80.12M |
| July 31, 2026 | 78.87M |
| July 30, 2026 | 86.95M |
| July 29, 2026 | 71.35M |
| July 28, 2026 | 76.92M |
| July 27, 2026 | 82.21M |
| July 24, 2026 | 89.73M |
| July 23, 2026 | 91.40M |
| July 22, 2026 | 94.47M |
| July 21, 2026 | 97.81M |
| July 20, 2026 | 91.12M |
| July 17, 2026 | 89.17M |
| July 16, 2026 | 79.98M |
| July 15, 2026 | 79.15M |
| July 14, 2026 | 84.72M |
| July 13, 2026 | 81.10M |
| July 10, 2026 | 84.44M |
| July 09, 2026 | 85.83M |
| July 08, 2026 | 90.57M |
| July 07, 2026 | 90.57M |
| July 06, 2026 | 88.62M |
| July 02, 2026 | 98.92M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ironwood Pharmaceuticals, Inc. | 991.92M |
| Theriva Biologics, Inc. | 3.579M |
| AbbVie, Inc. | 518.65B |
| Decoy Therapeutics, Inc. | -6.869M |
| Yarrow Bioscience, Inc. | -4.874M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.722M |
| Total Expenses (Quarterly) | 1.722M |
| EPS Diluted (Quarterly) | -0.064 |
| Earnings Yield | -30.18% |
| Normalized Earnings Yield | -27.59 |